Apricus appoints new development head
This article was originally published in Scrip
Executive Summary
Apricus Biosciences, a biopharmaceutical company focused on urology and rheumatology, has named Brian T Dorsey chief development officer, a newly established position at the company. Mr Dorsey will report to Richard Pascoe, Apricus' chief executive officer. Prior to joining Apricus, Mr Dorsey was senior vice-president of pharmaceutical development at Pernix Therapeutics.